Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK.

Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK.

OBJECTIVE:To evaluate the cost-effectiveness of adding bedaquiline to a background regimen (BR) of drugs for multidrug-resistant tuberculosis (MDR-TB) in the United Kingdom (UK). METHODS:A cohort-based Markov model was developed to estimate the incremental cost-effectiveness ratio of bedaquiline plu...

Full description

Bibliographic Details
Main Authors: Lara J Wolfson, Anna Walker, Robert Hettle, Xiaoyan Lu, Chrispin Kambili, Andrew Murungi, Gerhart Knerer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4368676?pdf=render

Similar Items

Similar Items